Condition
HFmrEF clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HFmrEF clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), United States (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
US benchmarking of heart and liver stiffness using shear wave ultrasound
This project will test whether a new ultrasound device can measure heart and liver stiffness using shear wave velocity in people aged 60 or older with preserved or mildly reduced ejection fraction and left ventricular hypertrophy, with or without transthyretin amyloid cardiomyopathy, and in control subjects.
-
Adding macitentan to dapagliflozin for people with HFmrEF/HFpEF and combined pre- and post-capillary pulmonary hypertension
This test will see if adding macitentan to dapagliflozin helps adults with HFmrEF or HFpEF who also have combined pre- and post-capillary pulmonary hypertension.
Related topics
Quick answers
How many HFmrEF clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.